PRA Health Sciences is a contract research organization engaged in providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. Co. has two reportable segments: Clinical Research, which performs a range of services across the spectrum of clinical development programs, from the filing of investigational new drug applications and similar regulatory applications to conducting all phases of clinical trials; and Data Solutions, which provides data, analytics, technology, and consulting solutions to the life sciences market including market intelligence services, consulting and services, and apps and technology. We show 27 historical shares outstanding datapoints in our coverage of PRAH's shares outstanding history.
Understanding the changing numbers of PRAH shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like PRAH versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching PRAH by allowing them to research PRAH shares outstanding history
as well as any other stock in our coverage universe. |
Free PRAH Email Alerts:
Video: Shares Outstanding Importance
